Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Investigating the role of Staphylococcus aureus IsdB protein in the mechanism for heme-uptake from human hemoglobin.

EF 2014-15

Résumé
Staphylococcus aureus is an important bacterial pathogen that causes a number of life-threatening diseases. Moreover, it has acquired resistance to many classes of antibiotics. The lack of effective antibiotics towards this infection has created a high demand for novel therapeutics. One of the essential growth requirements during S.aureus infection is iron as it is needed for many cellular processes. However, most iron in humans is stored in the form of heme bound to hemoglobin since tight regulation of iron grants nutritional immunity, and limits pathogen growth. The Iron Regulated Surface Determinants (Isd) system is to date the only heme-uptake pathway identified in S.aureus. IsdB is the receptor protein that binds to hemoglobin during heme uptake. The first aim of my research is to further elucidate the mechanism of heme transfer from hemoglobin to IsdB. I will construct IsdB variants and perform in-vitro binding assays to determine the effect of these mutations. In addition, previous protein assays done in the lab have shown that IsdB binds but is unable to extract heme from hemoglobin-haptoglobin complexes, which quickly forms in human serum during hemolysis. My second aim is understand how IsdB is able to extract heme from hemoglobin in the presence of haptoglobin. I am hypothesizing that there are other proteins involved in this interaction and I will be characterizing these interactions in-vitro and in-vivo using hemoglobin transfer assays and growth assays. In 2006, Merck & Co., Lnc. developed an IsdB vaccine, which, showed promising results in mice models, but failed during clinical trials. Understanding these proteins interactions at host-pathogen interface will help us to develop more effective and safer S.aureus vaccines.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
331513
Name
Li Jun Wen
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of Staphylococcus aureus IsdB protein in the mechanism for heme-uptake from human hemoglobin.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Haptoglobin; Heme Utilization Pathway; Hemoglobin; Iron Regulated; Isd System; Isdb; Isdh; Neat Domains; Staphylococcus Aureus; Vaccine Development
Abstract
Staphylococcus aureus is an important bacterial pathogen that causes a number of life-threatening diseases. Moreover, it has acquired resistance to many classes of antibiotics. The lack of effective antibiotics towards this infection has created a high demand for novel therapeutics. One of the essential growth requirements during S.aureus infection is iron as it is needed for many cellular processes. However, most iron in humans is stored in the form of heme bound to hemoglobin since tight regulation of iron grants nutritional immunity, and limits pathogen growth. The Iron Regulated Surface Determinants (Isd) system is to date the only heme-uptake pathway identified in S.aureus. IsdB is the receptor protein that binds to hemoglobin during heme uptake. The first aim of my research is to further elucidate the mechanism of heme transfer from hemoglobin to IsdB. I will construct IsdB variants and perform in-vitro binding assays to determine the effect of these mutations. In addition, previous protein assays done in the lab have shown that IsdB binds but is unable to extract heme from hemoglobin-haptoglobin complexes, which quickly forms in human serum during hemolysis. My second aim is understand how IsdB is able to extract heme from hemoglobin in the presence of haptoglobin. I am hypothesizing that there are other proteins involved in this interaction and I will be characterizing these interactions in-vitro and in-vivo using hemoglobin transfer assays and growth assays. In 2006, Merck & Co., Lnc. developed an IsdB vaccine, which, showed promising results in mice models, but failed during clinical trials. Understanding these proteins interactions at host-pathogen interface will help us to develop more effective and safer S.aureus vaccines.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Li, Jun Wen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~